UgenTec Gets CE-IVD for PCR Interpretation Software
News Oct 26, 2016
UgenTec, the Belgian bioinformatics company that is developing universal & intelligent PCR analysis software, has received its ISO 13485 certification. Quickly following the new certification, UgenTec also obtained the CE-IVD label for its first product, FastFinder.
SGS and the Belgian Accreditation Organization (BELAC) granted UgenTec the ISO-certificate for "design, development, manufacturing, installation, and service of in-vitro diagnostic software for analysis and interpretation of real-time PCR data." The company also implemented the harmonized standard IEC:62304 "software for medical devices."
"Obtaining ISO 13485 & the CE-IVD label is important to our company, not only does the certificate prove our expertise & advanced quality, but also gives us a significant competitive edge in today's market," says CEO Wouter Uten.
Besides maintaining its current quality management system, UgenTec is currently in its final stages of another seed funding investment round for the PCR software's development.
Algorithm Speeds Up Medical Image Analysis 1000 TimesNews
Medical image registration is a common technique that involves overlaying two images, such as magnetic resonance imaging (MRI) scans, to compare and analyze anatomical differences in great detail. Researchers have described a machine-learning algorithm that can register brain scans and other 3-D images more than 1,000 times more quickly using novel learning techniques.
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.